Agios’ PYRUKYND® (mitapivat) Approved in the European Union for Adults with Thalassemia
Go back to Agios’ PYRUKYND® (mitapivat) Approved in the European Union for Adults with Thalassemia| AGIOS PHARM (NASDAQ: AGIO) | Delayed: 35.62 +0.52 (1.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $35.10 | 52 Week High | $71.49 | |||
| Open | $34.82 | 52 Week Low | $33.50 | |||
| Day High | $35.80 | P/E | N/A | |||
| Day Low | $34.63 | EPS | $-1.18 | |||
| Volume | 369,469 | |||||
